Basic Information
Enesi Pharma is an innovative pharmaceutical company dedicated to developing new products that have the potential to transform vaccine performance and delivery, with a significant impact on global healthcare. The company's primary focus is on collaborating with global companies, government agencies, and non-governmental organizations to develop novel solid-dose vaccines for a range of infectious diseases and other selected conditions. Enesi’s ImplaVax™ formulation and device technology offers substantial potential benefits for patients, caregivers, healthcare professionals, and payers by enhancing efficiency, safety, ease of use, reliability, and stability, supported by strong patient preference over standard needles and syringes. Enesi’s experienced leadership team has a proven track record in the successful development and commercialization of innovative products, delivering high-value outcomes for all stakeholders.